HEADER TRANSFERASE 14-JAN-16 5FTO TITLE CRYSTAL STRUCTURE OF THE ALK KINASE DOMAIN IN COMPLEX WITH ENTRECTINIB COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALK TYROSINE KINASE RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN, UNP RESIDUES 1094-1407; COMPND 5 SYNONYM: ANAPLASTIC LYMPHOMA KINASE, ALK; COMPND 6 EC: 2.7.10.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 6 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_VECTOR: PVL1393; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PVL-GST-ALK-KD KEYWDS TRANSFERASE, KINASE INHIBITORS, CANCER, DRUG DISCOVERY, ALK, TRK, KEYWDS 2 ROS1, ANAPLASTIC LARGE CELL LYMPHOMA (ALCL), NON SMALL CELL LARGE KEYWDS 3 CANCER (NSCLC), NEUROBLASTOMA, COLORECTAL CANCER (CRC) EXPDTA X-RAY DIFFRACTION AUTHOR R.BOSSI,G.CANEVARI,M.FASOLINI,M.MENICHINCHERI,E.ARDINI,P.MAGNAGHI, AUTHOR 2 N.AVANZI,P.BANFI,L.BUFFA,L.CERIANI,M.COLOMBO,L.CORTI,D.DONATI, AUTHOR 3 E.FELDER,C.FIORELLI,F.FIORENTINI,A.GALVANI,A.ISACCHI,A.LOMBARDI AUTHOR 4 BORGIA,C.MARCHIONNI,M.NESI,C.ORRENIUS,A.PANZERI,E.PERRONE,E.PESENTI, AUTHOR 5 L.RUSCONI,M.B.SACCARDO,E.VANOTTI,P.ORSINI REVDAT 3 10-JAN-24 5FTO 1 REMARK REVDAT 2 27-APR-16 5FTO 1 JRNL REVDAT 1 06-APR-16 5FTO 0 JRNL AUTH M.MENICHINCHERI,E.ARDINI,P.MAGNAGHI,N.AVANZI,P.BANFI, JRNL AUTH 2 R.T.BOSSI,L.BUFFA,G.CANEVARI,L.CERIANI,M.COLOMBO,L.CORTI, JRNL AUTH 3 D.DONATI,M.FASOLINI,E.R.FELDER,C.FIORELLI,F.FIORENTINI, JRNL AUTH 4 A.GALVANI,A.ISACCHI,A.L.BORGIA,C.MARCHIONNI,M.NESI, JRNL AUTH 5 C.ORRENIUS,A.PANZERI,E.PESENTI,L.RUSCONI,B.M.SACCARDO, JRNL AUTH 6 E.VANOTTI,E.PERRONE,P.ORSINI JRNL TITL DISCOVERY OF ENTRECTINIB: A NEW 3-AMINOINDAZOLE AS A POTENT JRNL TITL 2 ANAPLASTIC LYMPHOMA KINASE (ALK), C-ROS ONCOGENE 1 KINASE JRNL TITL 3 (ROS1), AND PAN-TROPOMYOSIN RECEPTOR KINASES (PAN-TRKS) JRNL TITL 4 INHIBITOR. JRNL REF J.MED.CHEM. V. 59 3392 2016 JRNL REFN ISSN 0022-2623 JRNL PMID 27003761 JRNL DOI 10.1021/ACS.JMEDCHEM.6B00064 REMARK 2 REMARK 2 RESOLUTION. 2.22 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.6.0117 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.22 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 31.34 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 3 NUMBER OF REFLECTIONS : 15609 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.199 REMARK 3 R VALUE (WORKING SET) : 0.196 REMARK 3 FREE R VALUE : 0.257 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.200 REMARK 3 FREE R VALUE TEST SET COUNT : 863 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.22 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.28 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1064 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 93.63 REMARK 3 BIN R VALUE (WORKING SET) : 0.2450 REMARK 3 BIN FREE R VALUE SET COUNT : 54 REMARK 3 BIN FREE R VALUE : 0.3160 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2335 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 41 REMARK 3 SOLVENT ATOMS : 182 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.97 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.55000 REMARK 3 B22 (A**2) : -0.89000 REMARK 3 B33 (A**2) : 0.34000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.308 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.236 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.939 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.898 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2449 ; 0.008 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3325 ; 1.129 ; 1.996 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 299 ; 5.040 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 106 ;34.750 ;23.868 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 407 ;15.649 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 16 ;16.104 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 357 ; 0.077 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1868 ; 0.005 ; 0.022 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 5FTO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 14-JAN-16. REMARK 100 THE DEPOSITION ID IS D_1290066049. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-APR-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5417 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAR SCANNER 345 MM PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16537 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.210 REMARK 200 RESOLUTION RANGE LOW (A) : 35.030 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.5 REMARK 200 DATA REDUNDANCY : 5.800 REMARK 200 R MERGE (I) : 0.12000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.21 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.32 REMARK 200 COMPLETENESS FOR SHELL (%) : 83.4 REMARK 200 DATA REDUNDANCY IN SHELL : 5.50 REMARK 200 R MERGE FOR SHELL (I) : 0.53000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2XBA REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.30 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 18% PEG3350, 0.1 M TRIS/HCL PH 8.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 26.21750 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 52.54450 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 29.23550 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 52.54450 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 26.21750 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 29.23550 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PRO A 1139 REMARK 465 ASN A 1140 REMARK 465 ASP A 1141 REMARK 465 PRO A 1142 REMARK 465 ALA A 1280 REMARK 465 SER A 1281 REMARK 465 TYR A 1282 REMARK 465 TYR A 1283 REMARK 465 ARG A 1284 REMARK 465 LYS A 1285 REMARK 465 GLY A 1286 REMARK 465 GLY A 1402 REMARK 465 PRO A 1403 REMARK 465 LEU A 1404 REMARK 465 VAL A 1405 REMARK 465 GLU A 1406 REMARK 465 GLU A 1407 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A1279 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A1219 40.24 -143.90 REMARK 500 ARG A1248 -13.13 82.21 REMARK 500 ASP A1249 51.26 -146.02 REMARK 500 MET A1302 -85.95 -103.46 REMARK 500 SER A1332 -4.78 84.83 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE YMX A 2402 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5FTQ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE ALK KINASE DOMAIN IN COMPLEX WITH CMPD 17 DBREF 5FTO A 1094 1407 UNP Q9UM73 ALK_HUMAN 1094 1407 SEQADV 5FTO GLY A 1093 UNP Q9UM73 EXPRESSION TAG SEQRES 1 A 315 GLY PRO ASN TYR CYS PHE ALA GLY LYS THR SER SER ILE SEQRES 2 A 315 SER ASP LEU LYS GLU VAL PRO ARG LYS ASN ILE THR LEU SEQRES 3 A 315 ILE ARG GLY LEU GLY HIS GLY ALA PHE GLY GLU VAL TYR SEQRES 4 A 315 GLU GLY GLN VAL SER GLY MET PRO ASN ASP PRO SER PRO SEQRES 5 A 315 LEU GLN VAL ALA VAL LYS THR LEU PRO GLU VAL CYS SER SEQRES 6 A 315 GLU GLN ASP GLU LEU ASP PHE LEU MET GLU ALA LEU ILE SEQRES 7 A 315 ILE SER LYS PHE ASN HIS GLN ASN ILE VAL ARG CYS ILE SEQRES 8 A 315 GLY VAL SER LEU GLN SER LEU PRO ARG PHE ILE LEU LEU SEQRES 9 A 315 GLU LEU MET ALA GLY GLY ASP LEU LYS SER PHE LEU ARG SEQRES 10 A 315 GLU THR ARG PRO ARG PRO SER GLN PRO SER SER LEU ALA SEQRES 11 A 315 MET LEU ASP LEU LEU HIS VAL ALA ARG ASP ILE ALA CYS SEQRES 12 A 315 GLY CYS GLN TYR LEU GLU GLU ASN HIS PHE ILE HIS ARG SEQRES 13 A 315 ASP ILE ALA ALA ARG ASN CYS LEU LEU THR CYS PRO GLY SEQRES 14 A 315 PRO GLY ARG VAL ALA LYS ILE GLY ASP PHE GLY MET ALA SEQRES 15 A 315 ARG ASP ILE TYR ARG ALA SER TYR TYR ARG LYS GLY GLY SEQRES 16 A 315 CYS ALA MET LEU PRO VAL LYS TRP MET PRO PRO GLU ALA SEQRES 17 A 315 PHE MET GLU GLY ILE PHE THR SER LYS THR ASP THR TRP SEQRES 18 A 315 SER PHE GLY VAL LEU LEU TRP GLU ILE PHE SER LEU GLY SEQRES 19 A 315 TYR MET PRO TYR PRO SER LYS SER ASN GLN GLU VAL LEU SEQRES 20 A 315 GLU PHE VAL THR SER GLY GLY ARG MET ASP PRO PRO LYS SEQRES 21 A 315 ASN CYS PRO GLY PRO VAL TYR ARG ILE MET THR GLN CYS SEQRES 22 A 315 TRP GLN HIS GLN PRO GLU ASP ARG PRO ASN PHE ALA ILE SEQRES 23 A 315 ILE LEU GLU ARG ILE GLU TYR CYS THR GLN ASP PRO ASP SEQRES 24 A 315 VAL ILE ASN THR ALA LEU PRO ILE GLU TYR GLY PRO LEU SEQRES 25 A 315 VAL GLU GLU HET YMX A2402 41 HETNAM YMX ENTRECTINIB FORMUL 2 YMX C31 H34 F2 N6 O2 FORMUL 3 HOH *182(H2 O) HELIX 1 1 SER A 1104 LEU A 1108 5 5 HELIX 2 2 PRO A 1112 LYS A 1114 5 3 HELIX 3 3 SER A 1157 PHE A 1174 1 18 HELIX 4 4 LEU A 1204 THR A 1211 1 8 HELIX 5 5 ALA A 1222 ASN A 1243 1 22 HELIX 6 6 ALA A 1251 ARG A 1253 5 3 HELIX 7 7 PHE A 1271 ARG A 1279 1 9 HELIX 8 8 PRO A 1292 MET A 1296 5 5 HELIX 9 9 PRO A 1297 PHE A 1301 5 5 HELIX 10 10 THR A 1307 SER A 1324 1 18 HELIX 11 11 SER A 1334 SER A 1344 1 11 HELIX 12 12 PRO A 1355 TRP A 1366 1 12 HELIX 13 13 GLN A 1369 ARG A 1373 5 5 HELIX 14 14 ASN A 1375 ASP A 1389 1 15 HELIX 15 15 ASP A 1389 ASN A 1394 1 6 SHEET 1 AA 2 TYR A1096 PHE A1098 0 SHEET 2 AA 2 LYS A1101 SER A1103 -1 O LYS A1101 N PHE A1098 SHEET 1 AB 5 ILE A1116 GLY A1125 0 SHEET 2 AB 5 GLY A1128 VAL A1135 -1 O GLY A1128 N GLY A1125 SHEET 3 AB 5 LEU A1145 THR A1151 -1 O LEU A1145 N VAL A1135 SHEET 4 AB 5 PHE A1193 GLU A1197 -1 O ILE A1194 N LYS A1150 SHEET 5 AB 5 CYS A1182 SER A1186 -1 N ILE A1183 O LEU A1195 SHEET 1 AC 3 GLY A1202 ASP A1203 0 SHEET 2 AC 3 CYS A1255 LEU A1257 -1 N LEU A1257 O GLY A1202 SHEET 3 AC 3 ALA A1266 ILE A1268 -1 O LYS A1267 N LEU A1256 CISPEP 1 LEU A 1190 PRO A 1191 0 -5.04 SITE 1 AC1 17 LEU A1122 GLY A1123 PHE A1127 VAL A1130 SITE 2 AC1 17 ALA A1148 LEU A1196 GLU A1197 MET A1199 SITE 3 AC1 17 ALA A1200 GLY A1201 GLY A1202 ASP A1203 SITE 4 AC1 17 ARG A1253 ASN A1254 LEU A1256 GLY A1269 SITE 5 AC1 17 ASP A1270 CRYST1 52.435 58.471 105.089 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019071 0.000000 0.000000 0.00000 SCALE2 0.000000 0.017102 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009516 0.00000